Breakthrough in Cancer Care: FDA Approves Oncoguard-XL to Protect Patients During Chemotherapy
Breakthrough in Cancer Care: FDA Approves Oncoguard-XL to Protect Patients During Chemotherapy
[Opening shot: News studio, anchor seated at the desk.]
ANCHOR
"Good evening. In what doctors are calling a major leap forward in cancer care, the FDA has officially approved a new drug that could make chemotherapy safer and more tolerable for patients across the country."
[Cut to side screen: 'ONCOGUARD-XL APPROVED' with a soft graphic of a DNA helix and hospital imagery.]
ANCHOR
"The drug, called Oncoguard-XL, acts like a shield for healthy cells, dramatically reducing some of the most painful and dangerous side effects of chemotherapy without weakening its cancer-fighting power."
"For many patients, that could mean fewer infections, fewer hospital stays... and a lot less time spent recovering from the treatment itself."
[Footage rolls: clips of patients walking in hospital hallways, doctors reviewing charts, smiling families.]
ANCHOR
"Developed by Artemis Therapeutics, Oncoguard-XL uses a specially designed iron-glutamate compound to protect healthy tissues from the toxic effects of chemo drugs. Clinical trials showed promising results; patients saw up to a forty percent drop in serious complications like severe mouth sores and life-threatening infections."
"And perhaps most importantly: Oncoguard-XL didn’t interfere with the chemotherapy’s ability to destroy cancer cells."
[Cut back to Anchor at the desk.]
ANCHOR
"For survivors like Elena Ramirez, the drug has been life-changing."
[Roll clip: Elena, smiling softly, speaking.]
ELENA (clip):
"Before Oncoguard, I spent more time in the hospital than at home. After starting it, I could actually live through my treatment — not just survive it."
[Back to Anchor.]
ANCHOR
"The FDA says side effects from Oncoguard-XL were mild for most patients — things like nausea, dizziness, or a metallic taste. Doctors believe the benefits far outweigh the risks."
"Starting this June, the drug will be available nationwide for adult patients undergoing chemotherapy, with pediatric studies already underway."
[Screen shows a hotline number and website for patient assistance programs.]
ANCHOR
"And in a welcome move, Artemis Therapeutics is launching a financial assistance program to help patients afford the medication, especially those without full insurance coverage."
[Pause, warm smile.]
ANCHOR
"Tonight, for thousands of patients and families, this approval marks something more than just a new drug. It’s a new chapter of hope."
[Anchor transitions to the next segment.]
"Still ahead: how local communities are rallying to help veterans access critical mental health care. Stay with us."
Missing and Dead
ABC7 News
"-of this year, 1,400 San Francisco residents are missing, 20,000 in California at large. Many of the case details are sealed to the public, and the odds are likely that most won't be found alive. Our local SFPD has a homicide clearance rate of more than 90%, well above the national average, but lags behind in almost all other departments, including missing persons cases. In 2021, agencies involved in public health, women and family services, law enforcement and legal services reported 165 cases of human trafficking. The numbers are down from the 673 cases reported in 2017, but COVID-19 created barriers to entry for many agencies seeking to uncover, limit, and prosecute cases. Our-"